William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'

Go back to William Blair on Vera Therapeutics (VERA): 'We believe this update has positive read-through to companies developing novel therapies for IgAN'
Veramark Technologies, Inc. (NASDAQ: VERA) Delayed: 31.81 --0 (-0%)
Previous Close $31.81    52 Week High $1.18 
Open $31.81    52 Week Low $0.36 
Day High $31.81    P/E 530.17 
Day Low $31.81    EPS $0.06 
Volume 11